Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/24027
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Horakova, Dana | - |
dc.contributor.author | Uher, T. | - |
dc.contributor.author | Vaneckova, M. | - |
dc.contributor.author | Krasensky, J. | - |
dc.contributor.author | Seidl, Z. | - |
dc.contributor.author | van Pesch, V. | - |
dc.contributor.author | Lysandropoulos, A. | - |
dc.contributor.author | VAN WIJMEERSCH, Bart | - |
dc.contributor.author | Ribbens, A. | - |
dc.contributor.author | van Hecke, W. | - |
dc.contributor.author | Dong, Q. | - |
dc.contributor.author | Farkas, M. | - |
dc.contributor.author | Hyde, R. | - |
dc.contributor.author | Koendgen, H. | - |
dc.date.accessioned | 2017-07-19T15:05:51Z | - |
dc.date.available | 2017-07-19T15:05:51Z | - |
dc.date.issued | 2016 | - |
dc.identifier.citation | MULTIPLE SCLEROSIS JOURNAL, 22, p. 866-867 (Art N° P1641) | - |
dc.identifier.issn | 1352-4585 | - |
dc.identifier.uri | http://hdl.handle.net/1942/24027 | - |
dc.description.sponsorship | Supported by Biogen. DH: has received compensation for travel, speaker honoraria and consultant fees from Biogen, Novartis, Merck, Bayer, Sanofi Genzyme, and Teva, as well as research funding from Biogen. AL: has received research funding, honoraria as a speaker and member of advisory boards from Biogen, Sanofi Genzyme, Merck, Novartis, Bayer, Roche, Teva | - |
dc.language.iso | en | - |
dc.publisher | SAGE PUBLICATIONS LTD | - |
dc.title | Brain atrophy by automated MRI reading in long-term natalizumab treated patients: Real world data suggests brain atrophy rates in range of healthy individuals | - |
dc.type | Journal Contribution | - |
local.bibliographicCitation.conferencedate | SEP 14-17, 2016 | - |
local.bibliographicCitation.conferencename | 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) | - |
local.bibliographicCitation.conferenceplace | London, ENGLAND | - |
dc.identifier.epage | 867 | - |
dc.identifier.spage | 866 | - |
dc.identifier.volume | 22 | - |
local.format.pages | 2 | - |
local.bibliographicCitation.jcat | M | - |
dc.description.notes | [Horakova, D.; Uher, T.] Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic. [Horakova, D.; Uher, T.] Charles Univ Prague, Fac Med 1, Ctr Clin Neurosci, Prague, Czech Republic. [Vaneckova, M.; Krasensky, J.; Seidl, Z.] Charles Univ Prague, Fac Med 1, Dept Radiol, Prague, Czech Republic. [Vaneckova, M.; Krasensky, J.; Seidl, Z.] Gen Univ Hosp, Prague, Czech Republic. [van Pesch, V.] Catholic Univ Louvain, Clin Univ St Luc, Brussels, Belgium. [Lysandropoulos, A.] CUB Erasme Hosp, Dept Neurol, Brussels, Belgium. [van Wijmeersch, B.] Univ Hasselt, Overpelt, Belgium. [van Wijmeersch, B.] Rehabil & MS Ctr, Overpelt, Belgium. [Ribbens, A.; van Hecke, W.] Icometrix, Leuven, Belgium. [Dong, Q.; Farkas, M.; Hyde, R.; Koendgen, H.] Biogen, Cambridge, MA USA. | - |
local.publisher.place | LONDON | - |
local.type.refereed | Refereed | - |
local.type.specified | Meeting Abstract | - |
local.bibliographicCitation.artnr | P1641 | - |
local.class | dsPublValOverrule/author_version_not_expected | - |
dc.identifier.isi | 000383267203314 | - |
item.accessRights | Open Access | - |
item.fulltext | With Fulltext | - |
item.contributor | Horakova, Dana | - |
item.contributor | Uher, T. | - |
item.contributor | Vaneckova, M. | - |
item.contributor | Krasensky, J. | - |
item.contributor | Seidl, Z. | - |
item.contributor | van Pesch, V. | - |
item.contributor | Lysandropoulos, A. | - |
item.contributor | VAN WIJMEERSCH, Bart | - |
item.contributor | Ribbens, A. | - |
item.contributor | van Hecke, W. | - |
item.contributor | Dong, Q. | - |
item.contributor | Farkas, M. | - |
item.contributor | Hyde, R. | - |
item.contributor | Koendgen, H. | - |
item.fullcitation | Horakova, Dana; Uher, T.; Vaneckova, M.; Krasensky, J.; Seidl, Z.; van Pesch, V.; Lysandropoulos, A.; VAN WIJMEERSCH, Bart; Ribbens, A.; van Hecke, W.; Dong, Q.; Farkas, M.; Hyde, R. & Koendgen, H. (2016) Brain atrophy by automated MRI reading in long-term natalizumab treated patients: Real world data suggests brain atrophy rates in range of healthy individuals. In: MULTIPLE SCLEROSIS JOURNAL, 22, p. 866-867 (Art N° P1641). | - |
crisitem.journal.issn | 1352-4585 | - |
crisitem.journal.eissn | 1477-0970 | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Abstract.pdf | Peer-reviewed author version | 249.72 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.